SANNA, ALESSANDRO
SANNA, ALESSANDRO
Medicina Sperimentale e Clinica
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
2013 Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A.
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?
2013 Santini V; Schemenau J; Levis A; Balleari E; Sapena R; Adès L; Guerci A; Beyne-Rauzy O; Gourin MP; Cheze S; Stamatoullas A; Sanna A; Gioia D; Cametti G; Ferrero D; Raffoux E; Rose C; Poloni A; Prebet T; Legros L; Natarajan-Amé S; Fenaux P; Germing U; Dreyfus F; Park S.
Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients.
2012 Spinelli E;Caporale R;Buchi F;Masala E;Gozzini A;Sanna A;Sassolini F;Valencia A;Bosi A;Santini V
Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients.
2012 Spinelli E; Caporale R; Buchi F; Masala E; Gozzini A; Sanna A; Sassolini F; Valencia A; Bosi A; Santini V.
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis
2019 Balleari E.; Filiberti R.A.; Salvetti C.; Allione B.; Angelucci E.; Bruzzone M.; Calzamiglia T.; Cavaliere M.; Cavalleri M.; Cilloni D.; Clavio M.; Crisa E.; Da Col A.; Danise P.; Pilo F.; Ferrero D.; Finelli C.; Gioia D.; Lemoli R.M.; Masiera E.; Messa E.; Miglino M.; Musto P.; Natalie Oliva E.; Poloni A.; Salvi F.; Sanna A.; Scudeletti M.; Tassara R.; Santini V.
Effects of erythropoiesis-stimulating agents on overall survival of international prognostic scoring system low/intermediate-1 risk, transfusion-inde-pendent myelodysplastic syndrome patients: A cohort study
2019 Messa E.; Gioia D.; Masiera E.; Castiglione A.; Ceccarelli M.; Salvi F.; Danise P.; Sanna A.; Allione B.; Balleari E.; Poloni A.; Cametti G.; Ferrero D.; Tassara R.; Finelli C.; Bonferroni M.; Musto P.; Saglio G.; Levis A.; Santini V.
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine
2014 VALENCIA MARTINEZ, ANA BELEN; Masala, Erico; Rossi, A.; Martino, A.; Sanna, A.; Buchi, Francesca; Canzian, F.; Cilloni, D.; Gaidano, V.; Voso, M. T.; Kosmider, O.; Fontenay, M.; Gozzini, A.; Bosi, Alberto; Santini, Valeria
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine.
2014 Valencia A; Masala E; Rossi A; Martino A; Sanna A; Buchi F; Canzian F; Cilloni D; Gaidano V; Voso MT; Kosmider O; Fontenay M; Gozzini A; Bosi A; Santini V.
Hepcidin levels and their determinants in different types of myelodysplastic syndromes
2011 Santini V; Girelli D; Sanna A; Martinelli N; Duca L; Campostrini N; Cortelezzi A; Corbella M; Bosi A; Reda G; Olivieri O; Cappellini MD
Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells.
2012 E. Masala; A. Valencia; F. Buchi; D. Nosi; E. Spinelli; A. Gozzini; F. Sassolini; A. Sanna; S. Zecchi; A. Bosi; V. Santini
Impact of baseline cytogenetic findings and cytogenetic response on outcome of high-risk myelodysplastic syndromes and low blast count AML treated with azacitidine
2017 Sébert, Marie; Komrokji, Rami S; Sekeres, Mikkael A; Prebet, Thomas; Cluzeau, Thomas; Santini, Valeria; Gyan, Emmanuel; Sanna, Alessandro; Ali, Najla HAl; Hobson, Sean; Eclache, Virginie; List, Alan; Fenaux, Pierre; Adès, Lionel
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study
2017 Musto, Pellegrino; Maurillo, Luca; Simeon, Vittorio; Poloni, Antonella; Finelli, Carlo; Balleari, Enrico; Ricco, Alessandra; Rivellini, Flavia; Cortelezzi, Agostino; Tarantini, Giuseppe; Villani, Oreste; Mansueto, Giovanna; Milella, Maria R; Scapicchio, Daniele; Marziano, Gioacchino; Breccia, Massimo; Niscola, Pasquale; Sanna, Alessandro; Clissa, Cristina; Voso, Maria T; Fenu, Susanna; Venditti, Adriano; Santini, Valeria; Angelucci, Emanuele; Levis, Alessandro
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems
2017 Buckstein, Rena; Balleari, Enrico; Wells, Richard; Santini, Valeria; Sanna, Alessandro; Salvetti, Chiara; Crisà, Elena; Allione, Bernardino; Danise, Paolo; Finelli, Carlo; Clavio, Marino; Poloni, Antonella; Salvi, Flavia; Cilloni, Daniela; Oliva, Esther Natalie; Musto, Pellegrino; Houston, Brett; Zhu, Nancy; Geddes, Michelle; Leitch, Heather; Leber, Brian; Sabloff, Mitchell; Nevill, Thomas J; Yee, Karen W; Storring, John M; Francis, Janika; Maurillo, Luca; Latagliata, Roberto; Spiriti, Maria Antonietta Aloe; Andriani, Alessandro; Piccioni, Anna Lina; Fianchi, Luana; Fenu, Susanna; Gumenyuk, Svitlana; Buccisano, Francesco
Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia
2017 Valencia-Martinez, Ana; Sanna, Alessandro; Masala, Erico; Contini, Elisa; Brogi, Alice; Gozzini, Antonella; Santini, Valeria
Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis
2016 Gyan, Emmanuel; Andrieu, Valérie; Sanna, Alessandro; Caille, Agnès; Schemenau, Jennifer; Sudaka, Isabelle; Siguret, Virginie; Malet, Michèle; Park, Sophie; Bordessoule, Dominique; Mairesse, Jacques; Gelsi-Boyer, Véronique; Cheze, Stéphane; Beyne-Rauzy, Odile; Sébert, Marie; Sapena, Rosa; Zerazhi, Hacene; Legros, Laurence; Guerci-Bresler, Agnès; Amé, Shanti Natarjan; Germing, Ulrich; Santini, Valeria; Salvi, Flavia; Gioia, Daniela; Lunghi, Monia; Dreyfus, François; Fenaux, Pierre
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents
2017 Park, Sophie; Hamel, Jean-François; Toma, Andrea; Kelaidi, Charikleia; Thépot, Sylvain; Campelo, Maria Diez; Santini, Valeria; Sekeres, Mikkael A.; Balleari, Enrico; Kaivers, Jennifer; Sapena, Rosa; Götze, Katharina; Müller-Thomas, Catharina; Beyne-Rauzy, Odile; Stamatoullas, Aspasia; Kotsianidis, Ioannis; Komrokji, Rami; Steensma, David P.; Fensterl, Jaime; Roboz, Gail J.; Bernal, Teresa; Ramos, Fernando; Calabuig, Marisa; Guerci-Bresler, Agnès; Bordessoule, Dominique; Cony-Makhoul, Pascale; Cheze, Stéphane; Wattel, Eric; Rose, Christian; Vey, Norbert; Gioia, Daniela; Ferrero, Dario; Gaidano, Gianluca; Cametti, Giovanni; Pane, Fabrizio; Sanna, Alessandro; Germing, Ulrich; Sanz, Guillermo F.; Dreyfus, François; Fenaux, Pierre
PIEZO1 mutations impact on early clinical manifestations of myelodysplastic syndromes
2023 Attardi, Enrico; Andolfo, Immacolata; Russo, Roberta; Tiberi, Lucia; Raddi, Marco Gabriele; Rosato, Barbara Eleni; Marra, Roberta; Formicola, Daniela; Del Giudice, Federica; Brogi, Alice; Consagra, Angela; Amato, Cristina; Sanna, Alessandro; Artuso, Rosangela; Iolascon, Achille; Santini, Valeria
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents
2018 Duchmann M.; Yalniz F.F.; Sanna A.; Sallman D.; Coombs C.C.; Renneville A.; Kosmider O.; Braun T.; Platzbecker U.; Willems L.; Ades L.; Fontenay M.; Rampal R.; Padron E.; Droin N.; Preudhomme C.; Santini V.; Patnaik M.M.; Fenaux P.; Solary E.; Itzykson R.
Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine.
2012 Buchi F; Spinelli E; Masala E; Gozzini A; Sanna A; Bosi A; Ferrari G; Santini V.
Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine.
2012 Buchi, Francesca; Spinelli, E; Masala, E; Gozzini, A; Sanna, A; Bosi, Alberto; Ferrari, G; Santini, Valeria
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria. | 2013 | Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A. | |
| Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS? | 2013 | Santini V; Schemenau J; Levis A; Balleari E; Sapena R; Adès L; Guerci A; Beyne-Rauzy O; Gourin MP; Cheze S; Stamatoullas A; Sanna A; Gioia D; Cametti G; Ferrero D; Raffoux E; Rose C; Poloni A; Prebet T; Legros L; Natarajan-Amé S; Fenaux P; Germing U; Dreyfus F; Park S. | |
| Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients. | 2012 | Spinelli E;Caporale R;Buchi F;Masala E;Gozzini A;Sanna A;Sassolini F;Valencia A;Bosi A;Santini V | |
| Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients. | 2012 | Spinelli E; Caporale R; Buchi F; Masala E; Gozzini A; Sanna A; Sassolini F; Valencia A; Bosi A; Santini V. | |
| Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis | 2019 | Balleari E.; Filiberti R.A.; Salvetti C.; Allione B.; Angelucci E.; Bruzzone M.; Calzamiglia T.; Cavaliere M.; Cavalleri M.; Cilloni D.; Clavio M.; Crisa E.; Da Col A.; Danise P.; Pilo F.; Ferrero D.; Finelli C.; Gioia D.; Lemoli R.M.; Masiera E.; Messa E.; Miglino M.; Musto P.; Natalie Oliva E.; Poloni A.; Salvi F.; Sanna A.; Scudeletti M.; Tassara R.; Santini V. | |
| Effects of erythropoiesis-stimulating agents on overall survival of international prognostic scoring system low/intermediate-1 risk, transfusion-inde-pendent myelodysplastic syndrome patients: A cohort study | 2019 | Messa E.; Gioia D.; Masiera E.; Castiglione A.; Ceccarelli M.; Salvi F.; Danise P.; Sanna A.; Allione B.; Balleari E.; Poloni A.; Cametti G.; Ferrero D.; Tassara R.; Finelli C.; Bonferroni M.; Musto P.; Saglio G.; Levis A.; Santini V. | |
| Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine | 2014 | VALENCIA MARTINEZ, ANA BELEN; Masala, Erico; Rossi, A.; Martino, A.; Sanna, A.; Buchi, Francesca; Canzian, F.; Cilloni, D.; Gaidano, V.; Voso, M. T.; Kosmider, O.; Fontenay, M.; Gozzini, A.; Bosi, Alberto; Santini, Valeria | |
| Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. | 2014 | Valencia A; Masala E; Rossi A; Martino A; Sanna A; Buchi F; Canzian F; Cilloni D; Gaidano V; Voso MT; Kosmider O; Fontenay M; Gozzini A; Bosi A; Santini V. | |
| Hepcidin levels and their determinants in different types of myelodysplastic syndromes | 2011 | Santini V; Girelli D; Sanna A; Martinelli N; Duca L; Campostrini N; Cortelezzi A; Corbella M; Bosi A; Reda G; Olivieri O; Cappellini MD | |
| Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells. | 2012 | E. Masala; A. Valencia; F. Buchi; D. Nosi; E. Spinelli; A. Gozzini; F. Sassolini; A. Sanna; S. Zecchi; A. Bosi; V. Santini | |
| Impact of baseline cytogenetic findings and cytogenetic response on outcome of high-risk myelodysplastic syndromes and low blast count AML treated with azacitidine | 2017 | Sébert, Marie; Komrokji, Rami S; Sekeres, Mikkael A; Prebet, Thomas; Cluzeau, Thomas; Santini, Valeria; Gyan, Emmanuel; Sanna, Alessandro; Ali, Najla HAl; Hobson, Sean; Eclache, Virginie; List, Alan; Fenaux, Pierre; Adès, Lionel | |
| Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study | 2017 | Musto, Pellegrino; Maurillo, Luca; Simeon, Vittorio; Poloni, Antonella; Finelli, Carlo; Balleari, Enrico; Ricco, Alessandra; Rivellini, Flavia; Cortelezzi, Agostino; Tarantini, Giuseppe; Villani, Oreste; Mansueto, Giovanna; Milella, Maria R; Scapicchio, Daniele; Marziano, Gioacchino; Breccia, Massimo; Niscola, Pasquale; Sanna, Alessandro; Clissa, Cristina; Voso, Maria T; Fenu, Susanna; Venditti, Adriano; Santini, Valeria; Angelucci, Emanuele; Levis, Alessandro | |
| ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems | 2017 | Buckstein, Rena; Balleari, Enrico; Wells, Richard; Santini, Valeria; Sanna, Alessandro; Salvetti, Chiara; Crisà, Elena; Allione, Bernardino; Danise, Paolo; Finelli, Carlo; Clavio, Marino; Poloni, Antonella; Salvi, Flavia; Cilloni, Daniela; Oliva, Esther Natalie; Musto, Pellegrino; Houston, Brett; Zhu, Nancy; Geddes, Michelle; Leitch, Heather; Leber, Brian; Sabloff, Mitchell; Nevill, Thomas J; Yee, Karen W; Storring, John M; Francis, Janika; Maurillo, Luca; Latagliata, Roberto; Spiriti, Maria Antonietta Aloe; Andriani, Alessandro; Piccioni, Anna Lina; Fianchi, Luana; Fenu, Susanna; Gumenyuk, Svitlana; Buccisano, Francesco | |
| Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia | 2017 | Valencia-Martinez, Ana; Sanna, Alessandro; Masala, Erico; Contini, Elisa; Brogi, Alice; Gozzini, Antonella; Santini, Valeria | |
| Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis | 2016 | Gyan, Emmanuel; Andrieu, Valérie; Sanna, Alessandro; Caille, Agnès; Schemenau, Jennifer; Sudaka, Isabelle; Siguret, Virginie; Malet, Michèle; Park, Sophie; Bordessoule, Dominique; Mairesse, Jacques; Gelsi-Boyer, Véronique; Cheze, Stéphane; Beyne-Rauzy, Odile; Sébert, Marie; Sapena, Rosa; Zerazhi, Hacene; Legros, Laurence; Guerci-Bresler, Agnès; Amé, Shanti Natarjan; Germing, Ulrich; Santini, Valeria; Salvi, Flavia; Gioia, Daniela; Lunghi, Monia; Dreyfus, François; Fenaux, Pierre | |
| Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents | 2017 | Park, Sophie; Hamel, Jean-François; Toma, Andrea; Kelaidi, Charikleia; Thépot, Sylvain; Campelo, Maria Diez; Santini, Valeria; Sekeres, Mikkael A.; Balleari, Enrico; Kaivers, Jennifer; Sapena, Rosa; Götze, Katharina; Müller-Thomas, Catharina; Beyne-Rauzy, Odile; Stamatoullas, Aspasia; Kotsianidis, Ioannis; Komrokji, Rami; Steensma, David P.; Fensterl, Jaime; Roboz, Gail J.; Bernal, Teresa; Ramos, Fernando; Calabuig, Marisa; Guerci-Bresler, Agnès; Bordessoule, Dominique; Cony-Makhoul, Pascale; Cheze, Stéphane; Wattel, Eric; Rose, Christian; Vey, Norbert; Gioia, Daniela; Ferrero, Dario; Gaidano, Gianluca; Cametti, Giovanni; Pane, Fabrizio; Sanna, Alessandro; Germing, Ulrich; Sanz, Guillermo F.; Dreyfus, François; Fenaux, Pierre | |
| PIEZO1 mutations impact on early clinical manifestations of myelodysplastic syndromes | 2023 | Attardi, Enrico; Andolfo, Immacolata; Russo, Roberta; Tiberi, Lucia; Raddi, Marco Gabriele; Rosato, Barbara Eleni; Marra, Roberta; Formicola, Daniela; Del Giudice, Federica; Brogi, Alice; Consagra, Angela; Amato, Cristina; Sanna, Alessandro; Artuso, Rosangela; Iolascon, Achille; Santini, Valeria | |
| Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents | 2018 | Duchmann M.; Yalniz F.F.; Sanna A.; Sallman D.; Coombs C.C.; Renneville A.; Kosmider O.; Braun T.; Platzbecker U.; Willems L.; Ades L.; Fontenay M.; Rampal R.; Padron E.; Droin N.; Preudhomme C.; Santini V.; Patnaik M.M.; Fenaux P.; Solary E.; Itzykson R. | |
| Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine. | 2012 | Buchi F; Spinelli E; Masala E; Gozzini A; Sanna A; Bosi A; Ferrari G; Santini V. | |
| Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine. | 2012 | Buchi, Francesca; Spinelli, E; Masala, E; Gozzini, A; Sanna, A; Bosi, Alberto; Ferrari, G; Santini, Valeria |